`Trials@uspto.gov
`Paper 16
`571-272-7822 Entered: September 28, 2018
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`_____________
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`____________
`
`MYLAN TECHNOLOGIES, INC.,
`Petitioner,
`
`v.
`
`NOVEN PHARMACEUTICALS, INC.,
`Patent Owner.
`____________
`
`Case IPR2018-00174
`Patent 9,730,900 B2
`____________
`
`
`
`Before JAMES T. MOORE, SUSAN L. C. MITCHELL, and KRISTI L. R.
`SAWERT, Administrative Patent Judges.
`
`SAWERT, Administrative Patent Judge.
`
`
`
`
`
`
`ORDER
`
`Granting Joint Motion to Expunge
`37 C.F.R. § 42.5
`
`
`
`IPR2018-00174
`Patent 9,730,900 B2
`
`
`
`On September 26, 2018, Mylan Technologies, Inc. (“Petitioner”) and
`
`
`
`Noven Pharmaceuticals, Inc. (“Patent Owner”) filed a Joint Motion to
`
`Expunge Confidential Information. Paper 15. The parties request
`
`expungement of Exhibit 2024, which was filed under seal. Id. at 2.
`
`On September 5, 2018, pursuant to 35 U.S.C. § 317(a), the parties
`
`filed a Joint Motion to Terminate this proceeding. Paper 11. In light of the
`
`parties’ settlement, we entered an order terminating the proceeding.
`
`Paper 14. We did not rely on any information in the aforementioned exhibit
`
`to dispose of any issues in this proceeding. Our review of this exhibit
`
`indicates that it contains nonpublic information.
`
`Based on the record before us, the need to protect the confidential
`
`information in Exhibit 2024 outweighs the public interest in unsealing that
`
`exhibit. Accordingly, it is appropriate to expunge the exhibit from the
`
`record.
`
`Accordingly, it is:
`
`ORDERED that Exhibit 2024 be expunged from the record.
`
`
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`
`
`
`
`IPR2018-00174
`Patent 9,730,900 B2
`
`PETITIONER:
`
`Steven W. Parmelee
`sparmelee@wsgr.com
`
`Michael T. Rosato
`mrosato@wsgr.com
`
`Jad A. Mills
`jmills@wsgr.com
`
`
`PATENT OWNER:
`
`Courtenay C. Brinckerhoff
`cbrinckerhoff@foley.com
`
`Jason N. Mock
`jmock@foley.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`3
`
`